Photo of Maoxin Wu

Maoxin Wu

  • ADJUNCT PROFESSOR Pathology
Print ProfilePrint Profile

Research

  • Co-investigator of T. Godfrey in Molecular detection of occult metastases in lung cancer.
  • IRB proved clinical research project: Advanced therapeutic monitoring of head and neck squamous cell carcinoma via FNA and molecular studies.
  • Study of XIAP in lung lesions including benign, hyperplasia, atypical adenomatous hyperplasia and carcinomas and mesotheloma.
  • Immunohistochemical study of tumor makers in various types of Cancer.

Publications

Hu HP, Wu M. Mechanism of anesthetic action: oxygen pathway perturbation hypothesis. Med Hypotheses 2001 Nov; 57(5): 619-27.

Wu M, Putti TC, Bhuiya TA. Comparative study in the expression of p53, EGFR, TGF-α and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region. Appl Immunohistochem Mol Morphol 2002 Dec; 10(4): 351-6.

Hu H, Wu M. Spin-mediated consciousness theory: possible roles of neural membrane nuclear spin ensembles and paramagnetic oxygen. Med Hypotheses 2004; 63(4): 633-46.

Wu M, Burstein DE. Fine needle aspiration [review]. Cancer Invest 2004; 22(4): 620-8.

Wu M, Yuan S, Szporn AH, Gan L, Shtilbans V, Burstein DE. Immunocytochemical detection of XIAP in body cavity effusions and washes. Mod Pathol 2005 Dec; 18(12): 1618-22.

Wu M, Szporn AH, Zhang D, Wasserman P, Gan L, Miller L, Burstein DE. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Diagn Cytopathol 2005 Oct; 33(4): 223-7.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Wu did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central